Primo Chemicals Ltd Valuation Shifts Signal Renewed Price Attractiveness

Valuation Metrics Signal Improved Price Attractiveness

Primo Chemicals currently trades at a P/E ratio of 37.33, a significant improvement from previous levels that had been considered fair but less compelling. This valuation is notably more attractive when benchmarked against key peers in the commodity chemicals sector, many of whom are trading at substantially higher multiples. For instance, Sanstar and Stallion India are classified as expensive or very expensive, with P/E ratios of 67.42 and 50.23 respectively. Even Titan Biotech, another major player, commands a lofty P/E of 57.38.

The company’s price-to-book value stands at 1.43, reinforcing the shift towards a more reasonable valuation. This contrasts with some peers like Indo Borax & Chemicals, which, despite being very expensive, trade at a P/E of 29.01 but with a much higher PEG ratio, indicating less favourable growth-to-valuation balance. Primo’s PEG ratio of 0.11 is particularly noteworthy, suggesting undervaluation relative to its earnings growth potential.

Enterprise Value Multiples and Profitability Ratios

Examining enterprise value (EV) multiples, Primo Chemicals’ EV to EBITDA ratio is 10.36, which is lower than many peers such as Sanstar (57.94) and Stallion India (31.13), indicating a more attractive entry point on an operational earnings basis. The EV to EBIT ratio at 45.05 remains elevated but is consistent with the sector’s capital-intensive nature. Meanwhile, the EV to capital employed and EV to sales ratios, at 1.33 and 1.26 respectively, suggest the company is reasonably priced relative to its asset base and revenue generation.

However, profitability metrics remain modest. The latest return on capital employed (ROCE) is 2.95%, and return on equity (ROE) is 3.83%, both relatively low and signalling operational challenges or capital inefficiencies. These figures may temper enthusiasm despite the attractive valuation, underscoring the importance of monitoring operational improvements going forward.

Stock Price and Market Capitalisation Context

Primo Chemicals is classified as a micro-cap stock, with its current market price at ₹23.99, down 2.56% on the day from a previous close of ₹24.62. The stock’s 52-week high and low stand at ₹31.44 and ₹16.21 respectively, indicating a wide trading range and significant volatility. Today’s intraday range between ₹23.72 and ₹25.10 further reflects this price fluctuation.

While the recent price dip may concern some investors, it also contributes to the improved valuation metrics, making the stock more attractive on a relative basis. This dynamic is particularly relevant given the company’s recent downgrade in Mojo Grade from Buy to Hold on 22 June 2026, reflecting a more cautious stance amid mixed fundamentals and market conditions.

Comparative Performance: Primo Chemicals vs Sensex

Over various time horizons, Primo Chemicals’ stock returns have exhibited a mixed pattern when compared to the Sensex benchmark. In the short term, the stock outperformed the Sensex with a 1-week return of 1.18% versus the Sensex’s -0.21%, and a 1-month return of 9.84% compared to 2.09% for the Sensex. Year-to-date, however, the stock’s return is a marginal 0.17%, while the Sensex has declined by 9.66%.

Longer-term performance reveals more pronounced divergences. Over one year, Primo Chemicals has declined by 7.98%, slightly worse than the Sensex’s 6.17% fall. The three-year return is notably poor at -62.59%, contrasting sharply with the Sensex’s 22.25% gain. Conversely, over five and ten years, Primo Chemicals has delivered robust returns of 42.46% and an extraordinary 777.47% respectively, far outpacing the Sensex’s 46.10% and 191.66% gains. This suggests that while the stock has faced recent headwinds, its long-term growth trajectory remains impressive.

Peer Comparison Highlights Valuation Opportunities

Within the commodity chemicals sector, Primo Chemicals’ valuation stands out as attractive relative to several peers. Companies such as Gulshan Polyols and Oriental Aromatics also share an attractive valuation tag, with P/E ratios of 28.95 and 332.47 respectively, though the latter’s elevated P/E suggests a different growth or risk profile. Meanwhile, several peers including Stallion India, Titan Biotech, and I G Petrochems are classified as very expensive, with P/E ratios ranging from 50.23 to an extraordinary 615.06.

This valuation disparity highlights Primo Chemicals’ potential as a value proposition within its sector, especially for investors seeking exposure to commodity chemicals at a more reasonable price point. However, the company’s modest profitability metrics and micro-cap status warrant a cautious approach.

Outlook and Investment Considerations

Primo Chemicals’ recent valuation upgrade from fair to attractive reflects a recalibration of market expectations amid price softness and peer comparisons. The company’s low PEG ratio of 0.11 signals that earnings growth is not fully priced in, offering potential upside if operational efficiencies and profitability improve. However, the low ROCE and ROE figures indicate that the company must address capital utilisation and margin expansion to justify a higher rating.

Investors should weigh the stock’s micro-cap status and inherent volatility against its long-term growth record and improved valuation. The downgrade in Mojo Grade to Hold suggests a more cautious stance, recommending that investors monitor upcoming quarterly results and sector developments closely before committing fresh capital.

In summary, Primo Chemicals presents a compelling valuation case within the commodity chemicals sector, supported by improved P/E and P/BV ratios and a favourable PEG metric. Yet, operational challenges and recent price weakness counsel prudence, making it a stock suited for investors with a higher risk tolerance and a long-term horizon.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →